Ma-Jing Feng1, Wei-Bin Ning2, Wei Wang2, Zhong-Hua Lv2, Xin-Bing Liu2, Yong Zhu2, Wei Gao2, Hong-Ze Jin2, Shu-Shan Gao2. 1. Department of Neurosurgery, The Changxing People's Hospital, The Second Affiliated Hospital of Zhejiang University School of Medicine Changxing Campus, 66 Taihu Middle Road, Changxing 313100, China. Electronic address: ongiangang@163.com. 2. Department of Neurosurgery, The Changxing People's Hospital, The Second Affiliated Hospital of Zhejiang University School of Medicine Changxing Campus, 66 Taihu Middle Road, Changxing 313100, China.
Abstract
BACKGROUND: S100A12 is related to acute brain injury and inflammation. We investigated the clinical prognostic value of serum S100A12 in patients with severe traumatic brain injury (sTBI). METHODS: Serum S100A12, S100B, C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) concentrations were measured in 102 healthy controls and 102 sTBI patients. We recorded 30-day mortality and in-hospital major adverse events (IMAEs) including acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction. Trauma severity was assessed by admission Glasgow Coma Scale scores. RESULTS: When compared to the controls, serum S100A12, S100B, CRP, IL-6 and TNF-α concentrations were significantly increased in the patients. Serum concentrations of S100A12 significantly correlated with admission Glasgow Coma Scale scores and serum concentrations of S100B, CRP, IL-6 and TNF-α. Patients with any IMAEs or non-survivors within 30 days had obviously higher serum concentrations of S100A12, S100B, CRP, IL-6 and TNF-α than other remaining ones. Serum S100A2 was independently associated with IMAEs and 30-day mortality and overall survival. Receiver operating characteristic curve analysis showed that S100A12 concentrations had significant discriminatory ability for patients at risk of any IMAEs and death within 30 days. CONCLUSION: S100A12 might be associated with brain inflammation and evaluation of serum concentrations of S100A12 could be helpful in the early prognostic prediction in sTBI patients.
BACKGROUND:S100A12 is related to acute brain injury and inflammation. We investigated the clinical prognostic value of serum S100A12 in patients with severe traumatic brain injury (sTBI). METHODS: Serum S100A12, S100B, C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) concentrations were measured in 102 healthy controls and 102 sTBI patients. We recorded 30-day mortality and in-hospital major adverse events (IMAEs) including acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction. Trauma severity was assessed by admission Glasgow Coma Scale scores. RESULTS: When compared to the controls, serum S100A12, S100B, CRP, IL-6 and TNF-α concentrations were significantly increased in the patients. Serum concentrations of S100A12 significantly correlated with admission Glasgow Coma Scale scores and serum concentrations of S100B, CRP, IL-6 and TNF-α. Patients with any IMAEs or non-survivors within 30 days had obviously higher serum concentrations of S100A12, S100B, CRP, IL-6 and TNF-α than other remaining ones. Serum S100A2 was independently associated with IMAEs and 30-day mortality and overall survival. Receiver operating characteristic curve analysis showed that S100A12 concentrations had significant discriminatory ability for patients at risk of any IMAEs and death within 30 days. CONCLUSION:S100A12 might be associated with brain inflammation and evaluation of serum concentrations of S100A12 could be helpful in the early prognostic prediction in sTBI patients.
Authors: Setthasorn Zhi Yang Ooi; Robert James Spencer; Megan Hodgson; Samay Mehta; Nicholas Lloyd Phillips; Gwilym Preest; Susruta Manivannan; Matt P Wise; James Galea; Malik Zaben Journal: Neurosurg Rev Date: 2022-07-06 Impact factor: 2.800
Authors: Khashayar Mozaffari; Dillon Dejam; Courtney Duong; Kevin Ding; Alexis French; Edwin Ng; Komal Preet; Alyssa Franks; Isabelle Kwan; H Westley Phillips; Dennis Y Kim; Isaac Yang Journal: Cureus Date: 2021-08-10
Authors: Kira Trares; Megha Bhardwaj; Laura Perna; Hannah Stocker; Agnese Petrera; Stefanie M Hauck; Konrad Beyreuther; Hermann Brenner; Ben Schöttker Journal: Alzheimers Res Ther Date: 2022-09-09 Impact factor: 8.823